CGTN
A total of 832 counties, 128,000 villages and nearly 100 million people were living in poverty. This was the reality that China had to face. The task of providing support to them all wasn't easy, and making sure that everyone receives the exact help they needed was even harder.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210223005505/en/
"Who were these people and where were they located? If you are intent on leaving no one behind, then you have to locate each and every one of them and tailor relief measures accordingly," said Lin Wanlong, professor of economics and management at China Agriculture University.
In November 2013, during an inspection tour of central China's Hunan, Chinese President Xi Jinping first raised the concept of "targeted poverty alleviation." To crystalize it, he said one should "seek truth from facts, tailor measures to suit local conditions, give targeted guidance, and be meticulous about the work." These points have become the guiding principle in China's fight against poverty.
The first step of the targeted poverty alleviation campaign is to locate poverty through accurate identification, which means specifying survey data by matching it with individuals and households. Are there any better-off families in impoverished counties? Are there any poor households in rich townships? How does one differentiate whether a family really needs help? These were the first challenges that the campaign had to overcome.
"When I was just assigned to the township, I was informed that there were over 2,300 households and about 8,000 people living in poverty. But nobody knew who exactly they were," said Zhu Shengjiang, head of Yeping Town in Jiangxi Province's Ruijin City.
In a township of over 70,000 people, a poor population of over 8,000 was scattered among 399 villager groups. Zhu and his colleagues had to go door-to-door and look meticulously into their respective family conditions. Once poverty is identified, they would set up file for the households and log their information onto system.
The ultimate aim of poverty alleviation is to ensure people don't have to worry about food and clothing and have access to compulsory education, basic medical services and safe housing. Commonly known as the "two assurances and three guarantees," these are the key indicators for poverty relief officials to identify who exactly needs help.
"In each household, we look at things like whether there is sufficient working capacity, whether the child is receiving education and whether all family members are healthy. If the answer is no in all these categories, then we have found a household that really needs help," said Zeng Nenggui, director of poverty relief office in Ruijin City.
The launching of a national digital database has enabled data to cover each and every registered village, household and individual, which not only ensures the accuracy of poverty identification but helps nail down the causes of poverty for those who are in the system.
"These households are like a benchmark. What we do is to analyze their conditions and come up with tailor-made measures to lift them out of poverty," said Lu Chunsheng, director of the Information Center of the National Bureau of Rural Development. "For example, if a family remains poor because they couldn't receive proper education, our relief measures should include granting student loans and subsidies. If poverty is caused by a family member's poor health conditions, we then should provide them with sufficient healthcare."
Prescribing the right remedy is the key. Under President Xi's guidance, the targeted poverty alleviation campaign has five key measures.
Development & Production
All 832 registered counties have formulated industrial plans to fight against poverty, with over 300,000 industrial bases in farming, planting and processing being constructed on site.
Relocation
More than 96 million registered people have moved into over 2.66 million newly constructed houses, all equipped with water, electricity, gas and internet. Transportation is convenient with better roads built.
Ecological compensation
Over 1.1 million registered people have been employed as ecological forest rangers, directly lifting a total of 3 million out of poverty.
Education
About 200,000 students who dropped out of school due to poverty have now returned to school. More than 8 million students from poor families who failed to continue their studies or get employed after finishing high school have received vocational education for free.
Social security
Since 2016, a total of 19.36 million registered people have been included in the subsistence allowance, support and relief system.
To ensure that poverty is truly lifted, the strictest assessment system has been put in place. For each county to declare it has officially left poverty behind, it has to be thoroughly assessed by a third-party inspection team.
"We have never encountered such rigorous measures," said Zhang Shibin, former director of the poverty alleviation office of Yunnan Province's Luquan Yi and Miao Autonomous County. " During the third-party inspection, village officials are not even allowed to follow these teams into the village."
The targeted poverty alleviation campaign has perfectly embodied China's practical and down-to-earth approach in battling poverty, opening up a path that accommodates the country's realities while reflecting unique Chinese characteristics.
Original article: here .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005505/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
